IMPAX LABS FDA Approval ANDA 084214

ANDA 084214

IMPAX LABS

FDA Drug Application

Application #084214

Application Sponsors

ANDA 084214IMPAX LABS

Marketing Status

Discontinued002

Application Products

002TABLET;ORAL25MG0PROMETHAZINE HYDROCHLORIDEPROMETHAZINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1974-08-14
LABELING; LabelingSUPPL28AP2001-01-23
LABELING; LabelingSUPPL29AP1991-08-16
LABELING; LabelingSUPPL30AP1996-05-30
LABELING; LabelingSUPPL32AP1997-03-27
LABELING; LabelingSUPPL33AP1997-03-27

Submissions Property Types

SUPPL30Null1
SUPPL32Null1
SUPPL33Null1

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84214
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"PROMETHAZINE HYDROCHLORIDE","activeIngredients":"PROMETHAZINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"PROMETHAZINE HYDROCHLORIDE","submission":"PROMETHAZINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.